Bauhinia purpurea leaves’ extracts exhibited in vitro antiproliferative and antioxidant activities

The antiproliferative and antioxidant activities of various extracts of the leaves of Bauhinia purpurea were studied using in vitro standard assays. The aqueous and chloroform extracts successfully inhibited the proliferation of all cancer cells while the methanol extract inhibited the proliferation of all cells except the CEMss cells when assessed using the 3,(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) assay. The aqueous extract was effective against MCF-7 (IC50 ≈ 9 μg/ml), MDA-MB 231 (IC50 ≈ 17 μg/ml) and Caov-3 (IC50 ≈ 16 μg/ml); the chloroform extract was highly effective against the CEMss (IC50 ≈ 18 μg/ml) and HeLa (IC50 ≈ 21 μg/ml); and the methanol extract was highly effective only against the HL-60 (≈ 12 μg/ml) cell lines. Interestingly, all extracts did not inhibit the proliferation of 3T3 cells suggesting their non-cytotoxic properties. The aqueous and methanol, but not chloroform, extracts of B. purpurea (20, 100 and 500 μg/ml) exhibited concentration-dependent antioxidant activity only in the superoxide scavenging assay, but low to moderate activity in the 2,2- diphenyl-1 picrylhydrazyl (DPPH) radical scavenging assay, which could be associated with their total phenolic contents. In conclusion, the B. purpurea leaf possesses potential antiproliferative and concentration-dependent antioxidant activities. Purification and determination of active compounds are required for further study.Keywords: Bauhinia purpurea, in vitro, antiproliferative activity, antioxidant activity, phenolic compound

In vitro cytotoxic and antioxidant properties of the aqueous, chloroform and methanol extracts of Dicranopteris linearis leaves

The in vitro cytotoxic and antioxidant properties of the aqueous, chloroform and methanol extracts of the Dicranopteris linearis leaves were investigated in the present study. The cytotoxic effect was determined against the normal (3T3) and cancer cells’ lines (MCF-7, HeLa, HT-29, HL-60, K-562 and MDA-MB-231) using the 3,(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) assay, while the antioxidant activity was assessed using the DPPH radical and superoxide scavenging assays. Based on the results obtained, the aqueous extract was not effective against any of the types of cancer cells studied; the chloroform extract was effective only against MCF-7 and HeLa; and the methanol extract was effective against all the cancer cells used. Interestingly, all extracts failed to produce cytotoxic effect against the 3T3 cells (normal cell) indicating their safety. All extracts (20, 100 and 500 μg/ml) were found to exert antioxidant activity when tested using the DPPH radical and superoxide scavenging assays; with the methanol, followed by the aqueous and chloroform extracts exhibiting the highest antioxidant activity in both assays. The total phenolic content for the aqueous, methanol and chloroform extracts were 3112.1 ± 6.7, 3417.3 ± 4.7 and 1012.7 ± 5.3 mg/100 g gallic acid, respectively. In conclusion, the leaves of D. linearis possess potential cytotoxic activity against various types of cancer cell lines depending on the types of extracts used and antioxidant activity, which need to be further explored.Keywords: Dicranopteris linearis, in vitro anticancer activity, MTT assay, aqueous extract, chloroform extract, methanol extrac

Synthesis and preliminary assessment of the anticancer and Wnt/β-catenin inhibitory activity of small amide libraries of fenamates and profens

As part of an ongoing program to study the anticancer activity of non-steroidal anti-inflammatory drugs (NSAIDs) through generating diversity libraries of multiple NSAID scaffolds, we synthesized a series of NSAID amide derivatives and screened these sets against three cancer cell lines (prostate, colon and breast) and Wnt/β-catenin signaling. The evaluated amide analog libraries show significant anticancer activity/cell proliferation inhibition, and specific members of the sets show inhibition of Wnt/β-catenin signaling.</p